Karen Flynn

Ms. Karen A. Flynn is an Independent Director at Stevanato Group SpA, an Independent Director at Sotera Health Co., an Independent Director at Quanterix Corp., a Member at Healthcare Businesswomens Association and a Member at The Forum of Executive Women.
She is on the Board of Directors at Stevanato Group SpA, Sotera Health Co., Quanterix Corp., Germfree Laboratories LLC and The Franklin Institute.
Ms. Flynn was previously employed as a Chief Commercial Officer & Senior Vice President by Catalent, Inc., an Independent Director by Recro Pharma, Inc., a Chief Commercial Officer & Senior Vice President by West Pharmaceutical Services, Inc., a President-Biomodalities by Catalent Pharma Solutions, Inc., a Controller by MDeverywhere, Inc., a Principal by New York Life Insurance Co., a Principal by Sculptor Capital Management, Inc., and a Principal by The Bank of New York Co., Inc. She also served on the board at Catalent, Inc. and Chester County Economic Development Council.
She received her undergraduate degree from the University of Notre Dame, a graduate degree from the University of Pennsylvania and an MBA from Boston University.